Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone

Emerging Infectious Diseases - United States
doi 10.3201/eid2509.190105
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Centers for Disease Control and Prevention (CDC)

Related search

Heightened Vulnerability to MDR-TB Epidemics After Controlling Drug-Susceptible TB

PLoS ONE
Multidisciplinary
2010English

Improper Anti-Tb Treatment- Almost Certain Recipe for MDR-Tb

Journal of Evolution of Medical and Dental Sciences
2018English

Pyrido[1,2-A]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2011English

Ireland’s Potential MDR-TB and XDR-TB Problem

Irish Journal of Medical Science
Medicine
2010English

Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-Tb) Among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh

Journal of Tuberculosis Research
2018English

Relationship Between TB Treatment Phase and Knowledge of MDR TB With TB Patient’s Compliance

Jurnal Berkala Epidemiologi
2017English

Potential Drug–drug Interactions Between Antiretroviral Therapy and Treatment Regimens for Multi-Drug Resistant Tuberculosis: Implications for HIV Care of MDR-TB Co-Infected Individuals

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Second Line Drug Sensitivity Test of Multidrug Resistant Tuberculosis (MDR-TB) Isolates Using Proportional Method

Bayero Journal of Pure and Applied Sciences
2019English

Case Report: Multidrug-Resistant Tuberculosis (MDR TB)

Review of Primary Care Practice and Education (Kajian Praktik dan Pendidikan Layanan Primer)
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy